Bharat Biotech Ankleshwar plant gets Govt nod for Covaxin production
New Delhi: Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin.
"Govt of India approves vaccine manufacturing facility for production of @BharatBiotech''s #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted.
The approval would help increase availability of COVID-19 vaccines in the country, he added.
"Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted.
Read also: Bharat Biotech facility augmentation, 3 PSUs being supported for enhancing Covaxin production: Govt
In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility.
The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.
Read also: Canadian health regulator actively reviewing Covaxin data, says Bharat Biotech US, Canada partner
